Signal Point Asset Management, LLC Amgen Inc Transaction History

Signal Point Asset Management, LLC

$393 Million
Q3 2024

A detailed history of Signal Point Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Signal Point Asset Management, LLC holds 1,224 shares of AMGN stock, worth $342,732. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,224

Previous 1,224 -0.0%

Holding current value

$342,732

Previous $382,000 3.14%

% of portfolio

0.1%

Previous 0.11%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$262.75 - $319.31 $9,984 - $12,133	38 Added 3.2%	1,224 $382,000
Q1 2024 Apr 11, 2024	BUY	$268.87 - $324.56 $8,603 - $10,385	32 Added 2.77%	1,186 $337,000
Q3 2023 Oct 13, 2023	BUY	$218.65 - $271.46 $5,028 - $6,243	23 Added 2.03%	1,154 $310,000
Q2 2023 Jul 12, 2023	SELL	$214.27 - $253.37 $4,285 - $5,067	-20 Reduced 1.74%	1,131 $251,000
Q1 2023 Apr 14, 2023	SELL	$225.79 - $275.2 $3,386 - $4,128	-15 Reduced 1.29%	1,151 $278,000
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $18,093 - $22,989	-79 Reduced 6.35%	1,166 $0
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $224 - $253	1 Added 0.08%	1,245 $280,000
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $23,023 - $25,469	105 Added 9.22%	1,244 $301,000
Q4 2021 Jan 31, 2022	SELL	$198.88 - $227.6 $6,563 - $7,510	-33 Reduced 2.82%	1,139 $256,000
Q3 2021 Oct 28, 2021	BUY	$212.27 - $248.7 $15,495 - $18,155	73 Added 6.64%	1,172 $249,000
Q2 2021 Aug 03, 2021	BUY	$233.58 - $259.14 $12,846 - $14,252	55 Added 5.27%	1,099 $268,000
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $20,193 - $23,532	91 Added 9.55%	1,044 $260,000
Q4 2020 Jan 26, 2021	SELL	$216.38 - $257.67 $4,111 - $4,895	-19 Reduced 1.95%	953 $219,000
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $7,039 - $7,828	30 Added 3.18%	972 $247,000
Q2 2020 Jul 28, 2020	BUY	$197.81 - $242.74 $186,337 - $228,661	942 New	942 $222,000
Q1 2020 Apr 23, 2020	SELL	$182.24 - $241.7 $183,515 - $243,391	-1,007 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$189.21 - $243.2 $190,534 - $244,902	1,007 New	1,007 $242,000
Q4 2018 Jan 22, 2019	SELL	$178.4 - $208.25 $176,259 - $205,751	-988 Closed	0 $0
Q3 2018 Oct 31, 2018	BUY	$185.29 - $208.89 $183,066 - $206,383	988 New	988 $205,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signal Point Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signal Point Asset Management, LLC with notifications on news.

Account

Signal Point Asset Management, LLC Amgen Inc Transaction History